PhD
Nace Zidar
no.:
28905 
researcher – active in research organisation
| Code |
Science |
Field |
Subfield |
| 1.09.00 |
Natural sciences and mathematics |
Pharmacy |
|
| Code |
Science |
Field |
| B740 |
Biomedical sciences |
Pharmacological sciences, pharmacognosy, pharmacy, toxicology |
| B230 |
Biomedical sciences |
Microbiology, bacteriology, virology, mycology |
medicinal chemistry, drug design, drug synthesis, antibacterial compounds, anticancer compounds, topoisomerases, voltage-gated ion channels
Data for the last 5 years (citations for the last 10 years) on
April 22, 2024;
A3 for period
2018-2022
(update for tender in 2023:
YES)
| Database |
Linked records |
Citations |
Pure citations |
Average pure citations |
| WoS |
67 |
1,491 |
1,168 |
17.43 |
| Scopus |
68 |
1,610 |
1,272 |
18.71 |
Mentoring junior researchers
| no. |
Name and surname |
Type |
Period |
Code |
| 1 |
Martina Piga |
Bologna doctoral studies |
|
55894 |
| Level of education |
Professional title |
Study subject |
Faculty |
Year |
|
|
B. Sc. |
|
|
2006 |
|
Doctor's degree |
Ph. D. |
Pharmacy |
University of Ljubljana, Faculty of Pharmacy
|
2011 |
Doctoral dissertations and other final papers
Show
ARIS research and infrastructure programmes
Legend
Nace Zidar graduated from the Faculty of Pharmacy at the University of Ljubljana in 2006 under the supervision of Prof. Dr. Marko Anderluh. After graduation, he obtained a position as a young researcher in the Department of Pharmaceutical Chemistry at the Faculty of Pharmacy. In 2011, he defended his PhD thesis entitled "Design and synthesis of heterocyclic inhibitors of MurC-E ligases" under the supervision of Prof. Dr. Danijel Kikelj, for which he received the 2011 Krka Prize. From 2007-2011 he worked on the EU project INTAFAR, where he was involved in the design and synthesis of new inhibitors of peptidoglycan biosynthesis. In 2011-2015 he worked on the EU project MAREX, which aimed to discover new bioactive compounds from marine sources. In 2013-2015, he led a postdoctoral project funded by the Slovenian Research Agency entitled "Design, synthesis and evaluation of voltage-gated sodium channel modulators". He worked on the EU Marie Skłodowska-Curie ETN INTEGRATE and IMI project ENABLE (European Gramme-negative Antibacterial Engine), where he was involved in the discovery of compounds with activity against resistant Gram-negative bacteria. He is the leader of the research project funded by the Slovenian Research Agency for the discovery of inhibitors of the bacterial enzyme DNA gyrase. In 2017, he completed his postdoctoral training at the Department of Chemistry, University of Milan. His research interests include rational design, synthesis and evaluation of new bioactive compounds, especially with antibacterial (bacterial topoisomerase, Mur ligases) and anticancer activity (human topoisomerases, voltage-gated ion channels). He is also interested in physicochemical evaluation of compounds and development of instrumental analytical methods important in pharmacy.
ffa.uni-lj.si
